Search

Agilent Technologies Inc. has been issued a patent for fluid processing with withdraw-transfer modulation. The patent inventors are from various locations in Germany and the United States. The invention aims to improve fluid processing, particularly for two-dimensional chromatographic sample separation, by utilizing a fluid processing apparatus with specific components and functionalities. This patent provides detailed information on the apparatus and methods involved in the fluid processing system. [Extracted from the article]

A patent was issued to Agilent Technologies Inc. for a configurable injector designed to emulate the operation of another injector in a sample separation system. The invention aims to enhance the flexibility of injectors used in liquid chromatography by allowing them to mimic the operation of specific injectors. This technology enables the configurable injector to adjust various characteristics, such as fluid flow rate and pressure profile, to match those of the injector being emulated, ultimately improving the accuracy and consistency of sample separation results. [Extracted from the article]

Researchers at SSR College of Pharmacy have developed and validated a Reverse Phase High-Performance Liquid Chromatography method for accurately estimating a chemical related to empagliflozin, a sodium-glucose transporter 2 inhibitor. The method demonstrated successful chromatographic separation and accurate quantification, making it suitable for quality control of empagliflozin batches and impurities. This research contributes to the pharmaceutical industry's routine quality control practices. For more information, readers can access the full article titled "RP-HPLC Method Validation for Estimation of related Substances of Empagliflozin" in the Research Journal of Pharmacy and Technology. [Extracted from the article]

Agilent Technologies Inc. has been issued a patent for a sample management device that allows for branching off a defined amount of a fluidic sample without disrupting the flow in the source path. The device includes a fluidic valve that can establish a fluidic coupling point to temporarily divert a specific portion of the sample for further processing. This innovation aims to provide a flexible and precise sample management system for applications such as liquid chromatography. [Extracted from the article]

Researchers at SRM Institute of Science and Technology in India have developed a sustainable RP-HPLC method for simultaneously estimating aceclofenac, paracetamol, and serratiopeptidase. The method incorporates green and white analytical chemistry principles to ensure environmental sustainability and analytical efficiency. By adopting these practices, the researchers have created an innovative and environmentally friendly approach for the accurate analysis of pharmaceutical compounds. [Extracted from the article]

Shimadzu Corporation has been issued a patent for an analyzing method for azo compounds, developed to address the increasing need for testing hazardous substances in fiber products. Azo compounds, commonly found in synthetic dyes, can potentially produce cancer-causing substances. The patent outlines a method for efficiently and accurately analyzing a variety of azo compounds in fiber products and other samples using liquid chromatography coupled with mass spectrometry. This method aims to enhance the reliability of testing for hazardous substances, particularly in regions with strict regulations on azo compounds. [Extracted from the article]

A patent has been issued to Genzyme Corporation for methods to detect AAV (Adeno-Associated Virus) capsid serotypes using liquid chromatography/mass spectrometry (LC/MS). This method allows for the identification of different AAV capsid serotypes, which is crucial for gene therapy research and development. By analyzing viral particles, researchers can determine the serotype and heterogeneity of AAV particles, aiding in the design of more stable and efficient viral vectors for gene therapy applications. The patent provides detailed methods for analyzing AAV particles and determining post-translational modifications of viral proteins, offering valuable insights for the development of gene therapy products. [Extracted from the article]

Researchers at Genentech Inc. in South San Francisco have developed a method using anion exchange chromatography (AEX) to analyze the higher order structure (HOS) of large synthetic oligonucleotides, such as guide ribonucleic acid (gRNA). The AEX method showed superior resolution compared to other chromatographic methods commonly used for gRNA analysis. The study also found that gRNA has a unique HOS that differs from other therapeutic nucleic acids. This research has been peer-reviewed and published in the Journal of Chromatography A. For more information, readers can contact Bingchuan Wei at Genentech Inc. [Extracted from the article]

A patent has been issued to Agilent Technologies Inc. for a method of adjusting separation methods in sample separation apparatuses. The method involves carrying out an initial separation method, detecting sensor data during the process, and using numerical analysis to modify the separation method based on the detected data. The invention aims to simplify the development of separation methods for liquid chromatography devices. The patent provides detailed descriptions of the process, including the use of sensors, numerical analysis techniques, and modifications to operation parameters. [Extracted from the article]

New data from the University of Engineering and Technology highlights research in pharmaceutical sciences, specifically on the development and validation of a stability-indicating liquid chromatographic method for quantifying trifarotene in pure and topical drug products. Trifarotene is an effective treatment for acne and other skin issues. The developed analytical method is accurate, robust, and specific, making it suitable for routine pharmaceutical analysis of trifarotene to ensure its quality and safety. For more information, readers can refer to the Future Journal of Pharmaceutical Sciences article. [Extracted from the article]

Researchers from JSS College of Pharmacy in Karnataka, India have developed a sensitive and time-efficient method for quantifying Raloxifene Hydrochloride (RLX) in mice plasma using Reverse Phase High-Performance Liquid Chromatography (RP-HPLC). RLX is a drug known for its anti-cancer and anti-osteoporosis activity. The validated RP-HPLC method can be used for future pharmacokinetic (PK) interactions, PK analysis of formulations, and therapeutic drug monitoring. This research was supported by the Indian Council of Medical Research (ICMR) and has been peer-reviewed. [Extracted from the article]

A recent study conducted by researchers at the Faculty of Pharmacy in Karachi, Pakistan, has developed a high-performance liquid chromatography (HPLC) method for the quantitative determination of ondansetron, an antiemetic-antivertigo agent, in bulk and pharmaceutical dosage forms. The method was found to be specific, sensitive, and linear within the desired range, and showed good robustness and ruggedness. The researchers applied the proposed method to different marketed formulations. This research was supported by the Higher Education Commission of Pakistan and has been peer-reviewed. [Extracted from the article]

A recent report from Forensic Fluids Laboratories in Kalamazoo, Michigan discusses the detection of xylazine, a dangerous adulterant in illicit fentanyl use, in toxicology panels. The researchers developed methods for the screening and quantitation of xylazine in oral fluid, which is a popular testing medium due to its ease of collection and reflection of presence in blood for many classes of drugs. The study validated the method and confirmed xylazine concentrations in living human subject oral fluid samples ranging from 1.2 to 23.3 ng/mL. This research provides valuable insights into the detection and quantification of xylazine in toxicology testing. [Extracted from the article]

Researchers from Graz University of Technology in Austria have developed a stability-indicating method for the determination of carvedilol and felodipine in a combination oral dosage form. The method, developed using analytical quality by design (AQbD) principles, meets the regulatory requirements and can be used for the quantitative analysis of bulk, stability, and fixed-dose combination dosage form samples. The researchers believe that using AQbD principles can lead to high-quality data, lower operation costs, and minimum regulatory risk, and can pave the way for robust analytical methods for new dose combinations. [Extracted from the article]

A recent study conducted by researchers at Jiangxi University of Chinese Medicine explored the pharmacokinetic properties of Huai-hua Powder (HHP) in rats with ulcerative colitis (UC). The study aimed to develop a method to quantify five key components of HHP in rat plasma and compare the pharmacokinetic characteristics between normal rats and those with UC. The results showed significant differences in drug metabolism rates and extents between the two groups, suggesting potential clinical applications of HHP in treating UC. This research provides valuable insights into the use of HHP for UC treatment. [Extracted from the article]

A patent has been issued to Agilent Technologies Inc. for a two-dimensional fluid separation system. The system involves a first-dimension separation unit that separates a fluidic sample and a second-dimension separation unit that further separates the sample. A modulation unit and a second-dimension fluid drive are used to control the flow of the sample through the system. Unlike previous systems, this invention does not require a valve or switching unit between the first and second-dimension units. The patent provides a detailed description of the apparatus and its various components. [Extracted from the article]

Agilent Technologies Inc. has been issued a patent for fluid supply devices and a fluid member for forming a mobile phase in a sample separating device. The invention aims to generate a mobile phase with a precise composition for applications such as liquid chromatography. The fluid supply device includes a supply conduit, a fluid valve, an elastic buffer unit, and a fluid conveying unit. The integrally formed fluid member combines and mixes fluids to form the mobile phase, and it includes fluid inlets, a fluid combining unit, and a mixing unit. The patent provides detailed claims and additional information on the invention. [Extracted from the article]

A new report from the SRM Institute of Science and Technology in Tamil Nadu, India, presents fresh data on Phenylephrine Therapy. The research aimed to develop and validate a method for estimating caffeine, paracetamol, levocetirizine, and phenylephrine using reverse-phase high-performance liquid chromatography (RP-HPLC). The study utilized green analytical chemistry and analytical quality by design to create a greener method compared to previous approaches. The research concluded that the developed method was more environmentally friendly based on greenness evaluation tools. [Extracted from the article]

A study conducted by the University of Veterinary and Animal Sciences in Lahore, Pakistan, has developed a reliable and cost-effective method for therapeutic drug monitoring (TDM) of vancomycin, a glycopeptide antibiotic used to treat various infections. The method uses high-performance liquid chromatography (HPLC) to quantify vancomycin concentrations in human plasma. The study found that the developed method was sensitive enough to detect vancomycin concentrations as low as 0.25 mg/L and was accurate and precise in quantifying unknown concentrations. TDM results showed that 60% of the samples were within the target trough concentration range, indicating the effectiveness of the method. [Extracted from the article]

A recent study conducted by researchers at the Romanian Academy in Iasi, Romania, focuses on the development of a chromatographic analytical method for the identification and quantification of degradation products in a veterinary finished product containing enrofloxacin and bromhexine hydrochloride. The method utilized an Agilent Eclipse Plus C18 column and a mobile phase consisting of phosphoric acid and acetonitrile. The study found that the method successfully separated impurities of enrofloxacin and bromhexine hydrochloride, with up to 20 impurities for enrofloxacin and 7 impurities for bromhexine hydrochloride. The research also included method validation and demonstrated good selectivity, linearity, accuracy, precision, and recovery. [Extracted from the article]

Regeneron Pharmaceuticals Inc. has been issued a patent for high confidence compound identification by liquid chromatography-mass spectrometry. The patent describes a method of characterizing a sample by providing it to a liquid chromatography system, analyzing the separated sample components using multiplexed targeted selected ion monitoring, and performing iterative mass spectral data-dependent acquisition to identify individual sample components. The invention aims to improve data quality and characterization with higher confidence and less ambiguity. The patent was filed in May 2022 and published online in April 2024. [Extracted from the article]

A recent report from Medical University-Sofia in Bulgaria presents new findings in the field of gastroenterology. The study utilized chromatographic and in silico techniques to investigate the biotransformation of a potential neuroprotective compound in isolated rat hepatocytes. The researchers developed a novel chromatographic approach and used in silico modeling to predict metabolites. The results indicated the formation of glucuronide and glycine conjugates as the most probable products. This research provides valuable insights into the metabolism of the compound and its potential therapeutic applications. [Extracted from the article]

A patent has been issued to Agilent Technologies Inc. for the operation of an injector in a sample separation device. The invention aims to improve the reproducibility of sample separation results by controlling the injection process. The injector includes a control unit that generates overpressure in blocked partial paths of the injector path, fluidically couples the partial paths to release gas bubbles, and rinses the released gas bubble from the injector path. The patent also describes a method for controlling the injector and a sample separation device that incorporates the injector. This information is useful for researchers interested in sample separation techniques and technologies. [Extracted from the article]

A recent study conducted at Jena University Hospital in Germany focused on the analysis of pentaerythrityl tetranitrate (PETN) and its metabolites in human and ovine samples. PETN is a drug used in the treatment of coronary heart disease and heart failure, and its effects on pregnant patients with impaired placental perfusion were evaluated. The researchers developed a liquid chromatographic-mass spectrometric procedure to analyze the transfer of PETN and its metabolites from mother to fetus. The study found that the metabolites were transferred from mother to fetus with a slight time delay. [Extracted from the article]

A patent has been issued to Agilent Technologies Inc. for a multidimensional sample separation apparatus. The apparatus includes a first separation dimension with a fluid drive unit and a sample separation unit, and a second separation dimension with a fluid drive unit and two sample separation units. A switching mechanism allows for selective switching between the second and third sample separation units, and a control unit ensures that the pressure at the inlets of the sample separation units is substantially the same during switching. This apparatus is particularly useful for two-dimensional liquid chromatography. [Extracted from the article]

A patent has been issued to Agilent Technologies Inc. for a mounting device that simplifies the process of mounting a sample separation unit used in liquid chromatography. The device includes a swivel mechanism that allows for easy alignment and coupling of fluid connectors. The invention aims to make the mounting process more user-friendly and efficient, reducing the need for specialized expertise. This patent provides valuable information for researchers and professionals in the field of healthcare technology. [Extracted from the article]

A recent report from the National Cancer Institute (NCI) discusses research on kinase inhibitors, specifically palbociclib, ribociclib, and abemaciclib, which are commonly used in combination with letrozole for cancer treatment. The study aimed to develop and validate a method for monitoring the levels of these inhibitors and their metabolites in human plasma. The researchers successfully established an LC-MS/MS method for quantifying the compounds and found that it was suitable for measuring steady-state trough concentrations in patient samples. This research provides valuable insights into optimizing treatment outcomes for patients receiving CDK4/6is therapy. [Extracted from the article]

A recent report from the University of Diyala discusses a new method for determining the purity and formulating form of Cetrimide (CE) using Reverse Phase High Performance Liquid Chromatography (RP-HPLC). The researchers used a specific set of conditions and equipment to separate and analyze CE, achieving a calibration curve with a correlation coefficient of 0.9985. The method was successful in determining CE in pharmaceutical forms with an average recovery rate of 95.61% to 96.02%. This research provides valuable insights for the field of pharmacy and technology. [Extracted from the article]

A patent application has been submitted by researchers for a method of analyzing adeno-associated virus (AAV) particles using liquid chromatography/mass spectrometry (LC/MS). This method can identify different viral capsid serotypes and determine the heterogeneity of viral particles. It can be used in gene therapy research to improve targeted tissue tropism and study the impact of post-translation modifications on transfection potency and intracellular protein trafficking. The patent application provides detailed information on the specific techniques and conditions used in the methods. [Extracted from the article]

A recent report from researchers at Rajiv Gandhi Proudyogiki Vishwavidyalaya in Madhya Pradesh, India, focuses on the development and validation of a method for simultaneously analyzing quercetin and beta-sitosterol in plant extracts. Quercetin and beta-sitosterol are phytoconstituents with various pharmacological activities, including anti-inflammatory, anti-cancer, and anti-diabetic properties. The researchers used a reverse phase high-performance liquid chromatography (RP-HPLC) method with specific parameters to detect and quantify these compounds. The method was found to be accurate, precise, and specific, making it suitable for detecting quercetin and beta-sitosterol in food, biological samples, and marketed formulations. [Extracted from the article]

Researchers at Hubei University of Medicine have developed a new method for detecting and quantifying 14 different analgesics in postoperative analgesic solutions. The method utilizes HPLC-DAD and LC-MS/MS techniques and has been validated according to ICH guidelines. The researchers found that the proposed method showed good linear relationships, with low limits of quantitation and high precision and recovery rates. This method can be used for detecting drug abuse, as well as studying the stability and compatibility of analgesic solutions. [Extracted from the article]

Bio-Rad Laboratories Inc. has been issued a patent for a dynamic axial compression column for chromatography. The column includes a tube with a first and second opening, a first end plate assembly, a second end plate assembly, a plurality of rods, and a first plurality of compression devices. The column is designed to improve the efficiency of chromatographic separations by maintaining homogeneity and contact between the top plate and the packed bed. The patent provides detailed descriptions of the components and their configurations. [Extracted from the article]

A patent application titled "Computerized Device For Repeatedly Determining A Command To Control The Infusion Of Fluid In A Diabetic Patient" has been published online. The invention relates to the control of fluid infusion in diabetic patients, specifically in relation to the determination of insulin dosage. The invention aims to democratize the temporary target overrule function among diabetic patients, allowing them to easily define a temporary scheme for controlling insulin infusion. The computerized device includes a processor and a user interface with an actuable button to amend the standard scheme for a temporary period of time. The invention seeks to reduce the risk of hypoglycemia and provide convenience for diabetic patients. [Extracted from the article]

A patent has been issued to Uif (University Industry Foundation) Yonsei University for a microfluidic mixer and microfluidic device. The invention aims to selectively concentrate and detect cancer cell-derived exosomes from general exosomes in order to aid in cancer diagnosis and treatment. The microfluidic mixer includes a first microchannel with multiple disk-shaped mixing units, and the microfluidic device includes a second microchannel with separating units. The invention allows for efficient binding and detection of target materials at high flow rates. This patent provides a potential solution to the limitations of current exosome isolation and detection methods. [Extracted from the article]

A recent report from the University of Florida discusses the relationship between patient-reported and objectively measured internal rotation (IR) after reverse shoulder arthroplasty (RSA). The study found that while objective improvement in IR correlated with subjective functional gains, there was not always a uniform correlation between the ability to perform IR-related activities of daily living (IRADLs) and objective IR. The researchers suggest that future investigations should consider using patient-reported ability to perform IRADLs as the primary outcome measure for assessing postoperative IR. This research provides valuable insights for surgeons and patients considering RSA. [Extracted from the article]

The valve arrangement according to claim 8, wherein the coupling mechanism is configured as a bayonet mechanism, a screw mechanism or a mechanism using at least one fastening element. No. 9,845,894 B2 discloses a rotor valve having a stator and a rotor, which is in rotating sliding engagement for rotating with respect to the stator about a valve axis. The method according to claim 15, comprising, after the force-releasing: removing the stator from the valve module for exposing the rotor; and then replacing the rotor with a replacement rotor. [Extracted from the article]

In another aspect, the Applicant has developed a metabolite extraction solvent that is capable of extracting a broad spectrum of metabolites including the metabolites that have been identified as being relevant to predicting preeclampsia (Example 2, 3 and 4). "In one embodiment, the metabolite extraction solvent comprises methanol, isopropanol and an ammonium acetate buffer in a ratio of about 10:9:1 (v/v/v). "In one embodiment, the metabolite extraction solvent comprises methanol, isopropanol and an ammonium acetate buffer. [Extracted from the article]

Keywords: Angiology; Aorta; Atrial Fibrillation; Cardiac Arrhythmias; Health and Medicine; Heart Disease; Heart Disorders and Diseases; Risk and Prevention EN Angiology Aorta Atrial Fibrillation Cardiac Arrhythmias Health and Medicine Heart Disease Heart Disorders and Diseases Risk and Prevention 394 394 1 09/25/23 20230925 NES 230925 2023 SEP 25 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Fresh data on atrial fibrillation are presented in a new report. Angiology, Aorta, Atrial Fibrillation, Cardiac Arrhythmias, Health and Medicine, Heart Disease, Heart Disorders and Diseases, Risk and Prevention Incident atrial fibrillation was assessed from COA repair to last follow-up. [Extracted from the article]

"In some embodiments, the methods provided herein comprise determining the amount of testosterone in two human samples with a single mass spectrometric assay, the method comprising: i) subjecting each of two human samples to a different derivatizing agent to generate a differently derivatized testosterone in each of the two samples; ii) combining the two samples to form a multiplex sample; and iii) quantifying the amount of testosterone in each sample by mass spectrometry. "As used herein, the term "test sample" refers to any sample that may contain T. As used herein, the term "body fluid" means any fluid that can be isolated from the body of an individual. The methods include processing each patient sample differently to form a plurality of processed samples, wherein as a result of the processing, testosterone in each processed sample is distinguishable by mass spectrometry from the testosterone in other processed samples; combining the processed samples to form a multiplex sample; subjecting the multiplex sample to an ionization source under conditions suitable to generate one or more ions detectable by mass spectrometry, wherein one or more ions generated from testosterone from each processed sample are distinct from one or more ions of testosterone from the other processed samples; detecting the amount of one or more ions from testosterone from each processed sample by mass spectrometry; and relating the amount of one or more ions from testosterone from each processed sample to the amount of testosterone in each patient sample. In some preferred embodiments, a sample is a biological sample; that is, a sample obtained from any biological source, such as an animal, a cell culture, an organ culture, etc. [Extracted from the article]

Keywords: Antihyperlipidemic Agents; Cholesterol Absorption Inhibitors; Drugs and Therapies; Ezetimibe Therapy; Health and Medicine; High-Performance Liquid Chromatography; Imaging Technology; Pharmaceuticals; Technology EN Antihyperlipidemic Agents Cholesterol Absorption Inhibitors Drugs and Therapies Ezetimibe Therapy Health and Medicine High-Performance Liquid Chromatography Imaging Technology Pharmaceuticals Technology 1404 1404 1 09/19/23 20230922 NES 230922 2023 SEP 22 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Research findings on cholesterol absorption inhibitors are discussed in a new report. Keywords for this news article include: GITAM Deemed to be University, Antihyperlipidemic Agents, Pharmaceuticals, Ezetimibe Therapy, Imaging Technology, Drugs and Therapies, Health and Medicine, Cholesterol Absorption Inhibitors, High-Performance Liquid Chromatography. [Extracted from the article]

In the current study, the three most common representatives Amoxicilline (AMO), Metronidazole (MET) and Omeprazole (OME), respectively, are subjected to analysis through classical analytical procedure, providing high level accuracy, sensitivity and good separation abilities." A simple, specific, accurate and precise reverse phase-high performance liquid chromatographic method has been developed for the simultaneous determination of Amoxicillin Trihydrate (AMO), Metronidazole (MET) and Omeprazole (OME) in synthetic mixture. Keywords: 2-Pyridinylmethylsulfinylbenzimidazoles; Antiprotozoal Agents; Antiulcer Agents; Drugs and Therapies; Epsilonproteobacteria; Gram-Negative Bacteria; Health and Medicine; Helicobacter; Helicobacter pylori; Metronidazole Therapy; Nitroimidazoles; Omeprazole Therapy; Parasitic Diseases and Conditions; Proteobacteria EN 2-Pyridinylmethylsulfinylbenzimidazoles Antiprotozoal Agents Antiulcer Agents Drugs and Therapies Epsilonproteobacteria Gram-Negative Bacteria Health and Medicine Helicobacter Helicobacter pylori Metronidazole Therapy Nitroimidazoles Omeprazole Therapy Parasitic Diseases and Conditions Proteobacteria 2175 2175 1 09/11/23 20230915 NES 230915 2023 SEP 15 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Investigators publish new report on Helicobacter pylori. [Extracted from the article]

Oslo, Norway, Europe, Glucagon, Health and Medicine, Hormones, Nerve Tissue Proteins, Neuropeptides, Pancreatic Hormones, Peptide Hormones, Peptide Proteins, Pituitary Hormone Release Inhibiting Hormones, Proglucagon, Proinsulin, Somatostatin, Stem Cell Research Keywords for this news article include: Oslo, Norway, Europe, Glucagon, Health and Medicine, Hormones, Nerve Tissue Proteins, Neuropeptides, Pancreatic Hormones, Peptide Hormones, Peptide Proteins, Pituitary Hormone Release Inhibiting Hormones, Proglucagon, Proinsulin, Somatostatin, Stem Cell Research, University of Oslo. Keywords: Oslo; Norway; Europe; Glucagon; Health and Medicine; Hormones; Nerve Tissue Proteins; Neuropeptides; Pancreatic Hormones; Peptide Hormones; Peptide Proteins; Pituitary Hormone Release Inhibiting Hormones; Proglucagon; Proinsulin; Somatostatin; Stem Cell Research EN Oslo Norway Europe Glucagon Health and Medicine Hormones Nerve Tissue Proteins Neuropeptides Pancreatic Hormones Peptide Hormones Peptide Proteins Pituitary Hormone Release Inhibiting Hormones Proglucagon Proinsulin Somatostatin Stem Cell Research 2392 2392 1 09/11/23 20230911 NES 230911 2023 SEP 15 (NewsRx) -- By a News Reporter-Staff News Editor at Stem Cell Week -- Fresh data on Peptide Proteins - Pituitary Hormone Release Inhibiting Hormones are presented in a new report. [Extracted from the article]

Such impairment of fluorescent emission signals may have a pronounced negative effect on flow cytometry evaluation of stained particles of virus size, because of the smaller available area on such small particles to accommodate dye molecule attachment than on larger particles such as cells. Such blank fluid samples are stained in the same manner as the fluid samples with biological material under investigation and are subjected to the same flow cytometry evaluation to determine a blank particle count that is then subtracted from raw particle counts from flow cytometry results on the fluid samples under investigation. More recently, flow cytometry has been adapted for use to detect unassociated (free in solution) virus particles, typically referred to as virions, and other extremely small particles of biological material of a similar size to viruses, referred to as virus-size particles. One technique for correcting raw flow cytometry particle count results is to subtract from those raw results background particle counts determined from flow cytometry on blank fluid samples of the same or similar fluid matrix but without containing any particles. [Extracted from the article]

Pakistan, Asia, Anesthetics, Arthroplasty, Drugs and Therapies, Glycoconjugates, Glycoproteins, Health and Medicine, Local Injectable Anesthetics, Orthopedic Procedures, Peptides and Proteins, Pharmaceuticals, Ropivacaine Therapy, Surgery, Mardan Keywords: Mardan; Pakistan; Asia; Anesthetics; Arthroplasty; Drugs and Therapies; Glycoconjugates; Glycoproteins; Health and Medicine; Local Injectable Anesthetics; Orthopedic Procedures; Peptides and Proteins; Pharmaceuticals; Ropivacaine Therapy; Surgery EN Mardan Pakistan Asia Anesthetics Arthroplasty Drugs and Therapies Glycoconjugates Glycoproteins Health and Medicine Local Injectable Anesthetics Orthopedic Procedures Peptides and Proteins Pharmaceuticals Ropivacaine Therapy Surgery 2497 2497 1 08/14/23 20230818 NES 230818 2023 AUG 18 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Devices & Surgical Technology Week -- Investigators publish new report on Surgery - Arthroplasty. [Extracted from the article]

"Most devices currently available for isolation and detection of cells focus on capturing the cells only (for example using filter sieves), without retrieving the captured cells. In fact, rare cells isolated using available microfiltration devices easily adhere to the filters or other components of the devices impacting negatively on the retrieval efficiency or even preventing any cell to be retrieved for downstream analyses. [Extracted from the article]

Drugs and Therapies, High-Performance Liquid Chromatography, Imaging Technology, Pharmacy and Technology, Technology Keywords: Drugs and Therapies; High-Performance Liquid Chromatography; Imaging Technology; Pharmacy and Technology; Technology EN Drugs and Therapies High-Performance Liquid Chromatography Imaging Technology Pharmacy and Technology Technology 452 452 1 08/07/23 20230808 NES 230808 2023 AUG 11 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Data detailed on pharmacy and technology have been presented. [Extracted from the article]

Anesthetics, Arthroplasty, Drugs and Therapies, Glycoconjugates, Glycoproteins, Health and Medicine, Local Injectable Anesthetics, Orthopedic Procedures, Peptides and Proteins, Pharmaceuticals, Ropivacaine Therapy, Surgery Keywords: Anesthetics; Arthroplasty; Drugs and Therapies; Glycoconjugates; Glycoproteins; Health and Medicine; Local Injectable Anesthetics; Orthopedic Procedures; Peptides and Proteins; Pharmaceuticals; Ropivacaine Therapy; Surgery EN Anesthetics Arthroplasty Drugs and Therapies Glycoconjugates Glycoproteins Health and Medicine Local Injectable Anesthetics Orthopedic Procedures Peptides and Proteins Pharmaceuticals Ropivacaine Therapy Surgery 836 836 1 07/10/23 20230714 NES 230714 2023 JUL 14 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Investigators publish new report on arthroplasty. [Extracted from the article]